An interventional study of Video-oculography and Alternative prism cover test in Intermittent Exotropia and Strabismus, sponsored by Inje University. Status unknown at 1 site in Korea, Republic of. Open to participants aged 5 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-23.
Sponsored by Inje University · Not applicable, Interventional, and Diagnostic
Fifteen subjects with intermittent exotropia were included. The subjects were asked to fixate on a black-on-white optotype at 1 m, which subtended a visual angle of 50 min of arc, equating to a Snellen optotype of 20/200. The video files and data about ocular deviations were obtained using VOG with alternate cover test. Investigators analyzed angles of ocular deviations in dominant and non-dominant eyes, compared with values of VOG and deviation angles of the alternative prism cover test.
Exclusion Criteria:
Measurement: Video-oculography(VOG) measure and analyze angles of ocular deviations between dominant and non-dominant eye using VOG with alternate cover.
Diagnostic Test: Video-oculography
Measurement: Alternative prism cover test(APCT) measure and analyze angles of ocular deviations between dominant and non-dominant eye using APCT
Diagnostic Test: Alternative prism cover test
measure and analyze angles of ocular deviations between dominant and non-dominant eye using VOG with alternate cover.
measure and analyze angles of ocular deviations between dominant and non-dominant eye using APCT
The angles of ocular deviations between dominant and non-dominant eye using VOG with alternate cover
The angles of ocular deviations between dominant and non-dominant eye using VOG with alternate cover
Time frame: 2 weeks after approval
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Inje University